– Illustrative image from U.S. Patent No. 6,622,036
Today we are sharing a 2003 patent assigned to CNS Response, Inc. (As mentioned, we are featuring a foundational Pervasive Neurotech patent a day, from older to newer by issue date)
U.S. Patent No. 6,622,036: Method for classifying and treating physiologic brain imbalances using quantitative EEG.
- Assignee(s): CNS Response, Inc
- Inventor(s): Stephen Suffin
- Technology Category: EEG
- Issue Date: September 16, 2003
The ‘036 patent discloses the application of quantified EEG to brain imbalances (e.g., physiological imbalances). Read the rest of this entry »
By: Alvaro Fernandez
30,000+ scientists and professionals gathered for the annual Society for Neuroscience conference in Chicago last month, proving the growing interest and activities to better understand the inner workings of the human brain, and to discover ways and technologies to enhance its health and performance.
Now, which of all those ongoing efforts are closer to touching our lives, to empower consumers, patients and health professionals? Read the rest of this entry »
CNS Response is a cloud-based outcomes-sharing platform for EEG data. The purpose of the platform, named PEER (Psychiatric EEG Evaluation Registry) is to improve treatment decisions for psychiatric conditions by referencing the thousands of outcomes from previous trial instances. Read the rest of this entry »
Heads-up: Registration just closed for our webinar on how the Digital Revolution is meeting the Human Brain, building on the new report Pervasive Neurotechnology: A Groundbreaking Analysis of 10,000+ Patent Filings Transforming Medicine, Health, Entertainment and Business.
–> To learn more about the webinar and report, click HERE. Registered participants so far include innovators at IBM, Medtronic, Samsung, CNS Response, UCSF, Stanford, Intellectual Ventures, Neuroverse, Brain Resource, AARP, and more!
By: Alvaro Fernandez
Just a quick heads-up to the SharpBrains community: we are wrapping up a comprehensive market report on Pervasive Neurotechnologies (non-invasive, scalable, potentially ubiquitous). To learn when it becomes available, keep tuned via our e-Newsletter.
See below, in alphabetical order, a few of the organizations to be profiled in the report, given their relevant intellectual property portfolios (primarily patents). Read the rest of this entry »